Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease

Gigliola Alberti1, Juan Cristóbal Gana1, José L Santos2

  • 1Gastroenterology and Nutrition Department, Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 3580000, Chile.

Nutrients
|November 20, 2020
PubMed

Insights

Non-alcoholic fatty liver disease (NAFLD) is a growing concern in children, linked to obesity. Lifestyle changes, focusing on nutrition, are key for managing pediatric NAFLD due to limited drug options.

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Nutritional Science

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver condition in children and adults.
  • Rising pediatric obesity rates are driving a significant increase in NAFLD prevalence.
  • NAFLD is closely linked to metabolic syndrome, characterized by obesity, diabetes, and insulin resistance.

Purpose of the Study:

  • To review the literature on pediatric NAFLD.
  • To discuss the role of specific nutrients in NAFLD pathophysiology and management.
  • To highlight the importance of lifestyle modifications, particularly nutrition, for preventing and managing pediatric NAFLD.

Main Methods:

  • Literature review of scientific articles and studies.
  • Analysis of the role of fructose, Omega-3 fatty acids, and vitamin E in pediatric NAFLD.
  • Discussion of metabolic, inflammatory, and oxidative stress pathways involved in NAFLD.

Main Results:

  • Fructose consumption impacts NAFLD through metabolic pathways.
  • Omega-3 fatty acids demonstrate anti-inflammatory effects relevant to NAFLD.
  • Vitamin E plays a role in mitigating oxidative stress in NAFLD.

Conclusions:

  • Effective management of pediatric NAFLD necessitates lifestyle interventions, especially dietary changes.
  • Targeting key nutrients like fructose, Omega-3 fatty acids, and vitamin E may offer therapeutic benefits.
  • Further research into nutritional strategies is crucial for addressing the pediatric NAFLD epidemic.